Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 82
Validation of Toxicogenomic Technologies: A Workshop Summary APPENDIX C FEDERAL LIAISON GROUP FOR THE NRC COMMITTEE ON EMERGING ISSUES AND DATA ON ENVIRONMENTAL CONTAMINANTS Samuel Wilson, M.D., Chair Deputy Director National Institute of Environmental Health Sciences Research Triangle Park, NC William T. Allaben, Ph.D. Associate Director for Scientific Coordination FDA National Toxicology Program Liaison National Center for Toxicological Research U.S. Food and Drug Administration Jefferson, AR Nancy B. Beck, Ph.D., D.A.B.T. Toxicologist/Risk Assessor Office of Information and Regulatory Affairs Office of Management and Budget Washington, DC David A. Belluck, Ph.D. Senior Transportation Toxicologist FHWA/USDOT Washington, DC David Brown, M.P.H. Staff Assistant to the Director National Institute of Environmental Health Sciences Research Triangle Park, NC Richard A. Canady, Ph.D. Office of the Commissioner Food and Drug Administration Rockville, MD Daniel A. Casciano, Ph.D. Director National Center for Toxicological Research Food and Drug Administration Jefferson, AR Christopher De Rosa, Ph.D. Director, Division of Toxicology Agency for Toxic Substances and Disease Registry Atlanta, GA John Doll, Ph.D. Director United States Patent and Trademark Office Arlington, VA
OCR for page 83
Validation of Toxicogenomic Technologies: A Workshop Summary Amanda Edens, Ph.D. Director, Office of Chemical Hazards-Metals Directorate of Standards and Guidance OSHA/DOL Washington, DC William Farland, Ph.D. Acting Deputy Assistant Administrator for Science U.S. EPA Office of Research and Development Washington, DC Kevin Geiss, Ph.D. Office of Science and Technology Policy Executive Office of the President Washington, DC M. Olivia Harris, M.A., A.B.D. Senior Environmental Health Scientist Office of Science National Center for Environmental Health Agency for Toxic Substances and Disease Registry Atlanta, GA Robert Kavlock, Ph.D. Office of Research and Development U.S. Environmental Protection Agency Research Triangle Park, NC Don Marlowe, Ph.D. Agency Standards Coordinator Office of the Commissioner/OSHC Food and Drug Administration Rockville, MD Albert E. Munson, Ph.D. Director, Health Effects Laboratory Division National Institute for Occupational Safety and Health Morgantown, WV Lawrence Reiter, Ph.D. Director National Exposure Research Laboratory U.S. EPA Research Triangle Park, NC Carl M. Schroeder, Ph.D. U.S. Department of Agriculture Food Safety & Inspection Service Office of Public Health and Science Washington, DC Paul Schulte, Ph.D. Director, Education and Information Division National Institute for Occupational Safety and Health Robert A. Taft Laboratories Cincinnati, OH Karen K. Steinberg, Ph.D. Chief, Molecular Biology Branch National Center for Environmental Health Centers for Disease Control and Prevention Atlanta, GA Hal Zenick, Ph.D. Associate Director for Health National Health and Environmental Effects Research Laboratory U.S. Environmental Protection Agency Research Triangle Park, NC
OCR for page 84
Validation of Toxicogenomic Technologies: A Workshop Summary This page intentionally left blank.
Representative terms from entire chapter: